Ahmedabad-based Intas Pharmaceuticals Ltd has filed draft red-herring prospectus (DRHP) with the market regulator for an issue which will see ChrysCapital part-exit with over 13-14x returns, said ...
TO READ THE FULL STORY
- Definitive news, exclusives, analyses and videos
Exclusive reporting, expert analysis and commentary on PE/VC/M&A deals & dealmakers
Daily, weekly and monthly curated newsletters on the deal ecosystem in India
Breaking news alerts
Participation in marquee events at concessional rates
Comprehensive | Accurate | Unbiased | Impeccably sourced